Cigarette smoking by patients with serious mental illness, 1999-2016: An increasing disparity

Psychiatric Services

Volumn 69, Issue 2, 2018, Pages 147-153

  Dickerson, Faith ^a   Schroeder, Jennifer ^b   Katsafanas, Emily ^a   Khushalani, Sunil ^a   Origoni, Andrea E ^a   Savage, Christina ^a   Schweinfurth, Lucy ^a   Stallings, Catherine R ^a   Sweeney, Kevin ^a   Yolken, Robert H ^c  

^a SHEPPARD PRATT HEALTH SYSTEM   (United States)

^b Schroeder Statistical Consulting   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ALCOHOL ABUSE; ARTICLE; BIPOLAR DISORDER; BIPOLAR I DISORDER; BIPOLAR II DISORDER; CAUCASIAN; CIGARETTE; CIGARETTE SMOKING; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSIS RELATED GROUP; DRUG DEPENDENCE; DSM-IV; EDUCATION; FEMALE; GENDER; HEALTH DISPARITY; HUMAN; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PSYCHIATRIC DIAGNOSIS; RACE; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCHIZOPHRENIFORM DISORDER; SMOKING; SUBSTANCE ABUSE; YOUNG ADULT; ADOLESCENT; MARYLAND; MIDDLE AGED; MULTIVARIATE ANALYSIS; STATISTICAL MODEL; TRENDS;

ADOLESCENT; ADULT; AGED; BIPOLAR DISORDER; CIGARETTE SMOKING; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MARYLAND; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; SCHIZOPHRENIA; YOUNG ADULT;

EID: 85041455290     PISSN: 10752730     EISSN: 15579700     Source Type: Journal    
DOI: 10.1176/appi.ps.201700118     Document Type: Article

References (46)

1. Current Cigarette Smoking Among Adults in the United States. Atlanta, Centers for Disease Control and Prevention, 2017. https://www.cdc.gov/tobacco/data-statistics/fact-sheets/adult-data/cig-smoking/
2. de Leon J, Diaz FJ: Genetics of schizophrenia and smoking: an approach to studying their comorbidity based on epidemiological findings. Human Genetics 131:877-901, 2012
3. Jackson JG, Diaz FJ, Lopez L, et al: A combined analysis of worldwide studies demonstrates an association between bipolar disorder and tobacco smoking behaviors in adults. Bipolar Disorders 17:575-597, 2015
4. Liu NH, Daumit GL, Dua T, et al: Excess mortality in persons with severe mental disorders: a multilevel intervention framework and priorities for clinical practice, policy and research agendas. World Psychiatry 16:30-40, 2017
5. Dickerson F, Stallings C, Origoni A, et al: Mortality in schizophrenia: clinical and serological predictors. Schizophrenia Bulletin 40:796-803, 2014
6. Kelly DL, McMahon RP, Wehring HJ, et al: Cigarette smoking and mortality risk in people with schizophrenia. Schizophrenia Bulletin 37:832-838, 2011
7. Crompton D, Groves A, McGrath J: What can we do to reduce the burden of avoidable deaths in those with serious mental illness? Epidemiologia e Psichiatria Sociale 19:4-7, 2010
8. Tam J, Warner KE, Meza R: Smoking and the reduced life expectancy of individuals with serious mental illness. American Journal of Preventive Medicine 51:958-966, 2016
9. Olfson M, Gerhard T, Huang C, et al: Premature mortality among adults with schizophrenia in the United States. JAMA Psychiatry 72:1172-1181, 2015
10. Dickerson F, Stallings CR, Origoni AE, et al: Cigarette smoking among persons with schizophrenia or bipolar disorder in routine clinical settings, 1999-2011. Psychiatric Services 64:44-50, 2013
11. Paoletti L, Jardin B, Carpenter MJ, et al: Current status of tobacco policy and control. Journal of Thoracic Imaging 27:213-219, 2012
12. Cole HM, Fiore MC: The war against tobacco: 50 years and counting. JAMA 311:131-132, 2014
13. Frieden TR: Tobacco control progress and potential. JAMA 311: 133-134, 2014
14. Williams JM, Stroup TS, Brunette MF, et al: Tobacco use and mental illness: a wake-up call for psychiatrists. Psychiatric Services 65:1406-1408, 2014
15. Prochaska JJ, Das S, Young-Wolff KC: Smoking, mental illness, and public health. Annual Review of Public Health 38:165-185, 2017
16. Resources to Help Patients Quit Smoking. Arlington, VA, American Psychiatric Association, 2016. https://www.psychiatry.org/newsroom/apa-blogs/apa-blog/2016/03/resources-to-help-patients-quitsmoking
17. Schroeder SA, Morris CD: Confronting a neglected epidemic: tobacco cessation for persons with mental illnesses and substance abuse problems. Annual Review of Public Health 31:297-314, 1p, 314, 2010
18. Evins AE, Cather C, Pratt SA, et al: Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: a randomized clinical trial. JAMA 311: 145-154, 2014
19. Brody AL, Zorick T, Hubert R, et al: Combination extended smoking cessation treatment plus home visits for smokers with schizophrenia: a randomized controlled trial. Nicotine and Tobacco Research 19:68-76, 2017
20. Gilbody S, Peckham E, Man MS, et al: Bespoke smoking cessation for people with severe mental ill health (SCIMITAR): a pilot randomised controlled trial. Lancet Psychiatry 2:395-402, 2015
21. Chengappa KN, Perkins KA, Brar JS, et al: Varenicline for smoking cessation in bipolar disorder: a randomized, double-blind, placebocontrolled study. Journal of Clinical Psychiatry 75:765-772, 2014
22. Anthenelli RM, Benowitz NL, West R, et al: Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial. Lancet 387:2507-2520, 2016
23. Inpatient Psychiatric Facility Quality Reporting Program Manual. Baltimore, Centers for Medicare and Medicaid Services, 2016. http://www.qualityreportingcenter.com/wp-content/uploads/2016/06/IPF-CY2016-IPFQRManual-Guide-20160607-FINAL.pdf1-.pdf
24. Steinberg ML, Williams JM, Li Y: Poor mental health and reduced decline in smoking prevalence. American Journal of Preventive Medicine 49:362-369, 2015
25. Cook BL, Wayne GF, Kafali EN, et al: Trends in smoking among adults with mental illness and association between mental health treatment and smoking cessation. JAMA 311:172-182, 2014
26. Forman-Hoffman VL, Hedden SL, Glasheen C, et al: The role of mental illness on cigarette dependence and successful quitting in a nationally representative, household-based sample of U.S. adults. Annals of Epidemiology 26:447-454, 2016
27. First M, Gibbon M, Spitzer RL, et al: User's Guide for the SCID-I, Structured Clinical Interview for DSM IV Axis I Disorders. New York, Biometrics Research, 1996
28. First M, Gibbon M, Spitzer RL, et al: Structured Clinical Interview for DSM-IV Disorders, Non-Patient Edition. New York, Biometrics Research, 1998
29. Werner S, Malaspina D, Rabinowitz J: Socioeconomic status at birth is associated with risk of schizophrenia: population-based multilevel study. Schizophrenia Bulletin 33:1373-1378, 2007
30. Randolph C, Tierney MC, Mohr E, et al: The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity. Journal of Clinical and Experimental Neuropsychology 20:310-319, 1998
31. Kay SR, Fiszbein A, Opler LA: The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin 13:261-276, 1987
32. Tobacco Cessation. Rockville, MD, Substance Abuse and Mental Health Services Administration, 2017. http://www.integration. samhsa.gov/health-wellness/wellness-strategies/tobacco-cessation-2
33. Prochaska JJ: Smoking and mental illness: breaking the link. New England Journal of Medicine 365:196-198, 2011
34. Chen J, Bacanu SA, Yu H, et al: Genetic relationship between schizophrenia and nicotine dependence. Scientific Reports 6:25671, 2016
35. Freedman R: a7-nicotinic acetylcholine receptor agonists for cognitive enhancement in schizophrenia. Annual Review of Medicine 65: 245-261, 2014
36. Haig G, Wang D, Othman AA, et al: The a7 nicotinic agonist ABT-126 in the treatment of cognitive impairment associated with schizophrenia in nonsmokers: results from a randomized controlled phase 2b study. Neuropsychopharmacology 41:2893-2902, 2016
37. Walling D, Marder SR, Kane J, et al: Phase 2 trial of an alpha-7 nicotinic receptor agonist (TC-5619) in negative and cognitive symptoms of schizophrenia. Schizophrenia Bulletin 42:335-343, 2016
38. Hahn B, Harvey AN, Concheiro-Guisan M, et al: A test of the cognitive self-medication hypothesis of tobacco smoking in schizophrenia. Biological Psychiatry 74:436-443, 2013
39. Taylor G, McNeill A, Girling A, et al: Change in mental health after smoking cessation: systematic review and meta-analysis. BMJ 348: g1151, 2014
40. Gurillo P, Jauhar S, Murray RM, et al: Does tobacco use cause psychosis? Systematic review and meta-analysis. Lancet. Psychiatry 2:718-725, 2015
41. Gage SH, Jones HJ, Taylor AE, et al: Investigating causality in associations between smoking initiation and schizophrenia using Mendelian randomization. Scientific Reports 7:40653, 2017
42. Ziedonis DM, Kosten TR, Glazer WM, et al: Nicotine dependence and schizophrenia. Hospital and Community Psychiatry 45:204-206, 1994
43. How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease. Atlanta, Centers for Disease Control and Prevention, 2010
44. de Leon J, Diaz FJ: A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophrenia Research 76:135-157, 2005
45. Baker A, Richmond R, Haile M, et al: Characteristics of smokers with a psychotic disorder and implications for smoking interventions. Psychiatry Research 150:141-152, 2007
46. Dixon L, Medoff DR, Wohlheiter K, et al: Correlates of severity of smoking among persons with severe mental illness. American Journal on Addictions 16:101-110, 2007